Last reviewed · How we verify

NCT06772311

Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit

Not yet recruiting Last updated 13 January 2025
What this trial tests

trial in Atlantoaxial Dislocation in 300 participants. Not yet recruiting.

Timeline
15 January 2025
Primary endpoint
31 December 2025
31 December 2030

Quick facts

Lead sponsorPeking University Third Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment300
Start date15 January 2025
Primary completion31 December 2025
Estimated completion31 December 2030
Sites1 location across China

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Eligibility, any sex, with Atlantoaxial Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study was to learn about the long-term clinical efficacy of conservative treatment in atlantoaxial dislocation patients without neurological deficit. The main question it aims to answer is: Is surgical intervention always necessary in atlantoaxial dislocation patients without nerve deficit? Patients who refuse surgical intervention will continue to be treated conservatively. Clinical outcomes will be summarized over five years of follow-up

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atlantoaxial Dislocation

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06772311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing